{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:53:50Z","timestamp":1772121230990,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mehy.2005.01.027","type":"journal-article","created":{"date-parts":[[2005,3,11]],"date-time":"2005-03-11T11:20:28Z","timestamp":1110540028000},"page":"114-122","source":"Crossref","is-referenced-by-count":16,"title":["Migraine prophylactic drugs work via ion channels"],"prefix":"10.1016","volume":"65","author":[{"given":"Gary L.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mehy.2005.01.027_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0025-7125(05)70352-7","article-title":"Mechanism of migraine and action of antimigraine medications","volume":"85","author":"Spierings","year":"2001","journal-title":"Med Clinic North Am"},{"key":"10.1016\/j.mehy.2005.01.027_bib2","series-title":"Headache and other head pain","author":"Wolff","year":"1963"},{"key":"10.1016\/j.mehy.2005.01.027_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/ana.410090406","article-title":"Focal hyperemia followed by spreading oligemia and impaired activation of RCBF in classic migraine","volume":"9","author":"Olesen","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mehy.2005.01.027_bib4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/jcbfm.1984.79","article-title":"Long-lasting reduction of cortical blood flow of the rat brain after spreading depression with preserved autoregulation and impaired CO2 response","volume":"4","author":"Lauritzen","year":"1984","journal-title":"J Cereb Blood Flow Metabol"},{"key":"10.1016\/j.mehy.2005.01.027_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/jn.1944.7.6.359","article-title":"Spreading depression of activity in cerebral cortex","volume":"7","author":"Leao","year":"1944","journal-title":"J Neurophys"},{"issue":"7","key":"10.1016\/j.mehy.2005.01.027_bib6","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nm0795-658","article-title":"Brain stem activation in spontaneous human migraine attacks","volume":"1","author":"Weiller","year":"1995","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.mehy.2005.01.027_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0733-8619(18)30319-0","article-title":"The concept of migraine as state of central neuronal hyperexcitability","volume":"8","author":"Welch","year":"1990","journal-title":"Neurol Clin"},{"key":"10.1016\/j.mehy.2005.01.027_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1468-2982.1988.0802083.x","article-title":"Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids: a possible mechanism in vascular headache","volume":"8","author":"Markowitz","year":"1988","journal-title":"Cephalalgia"},{"key":"10.1016\/j.mehy.2005.01.027_bib9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/brain\/123.8.1703","article-title":"The development of cutaneous allodynia during a migraine attack","volume":"123","author":"Burstein","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2005.01.027_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/384560a0","article-title":"Sensitization of meningeal sensory neurons and the origins of headaches","volume":"384","author":"Strassman","year":"1996","journal-title":"Lett Nat"},{"key":"10.1016\/j.mehy.2005.01.027_bib11","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archneur.61.11.1665","article-title":"Channels and disease. Past, present, and future","volume":"61","author":"Ptacek","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2005.01.027_bib12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/brain\/awf130","article-title":"The neuronal channelopathies","volume":"125","author":"Kullmann","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.mehy.2005.01.027_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/archneur.61.6.926","article-title":"No mutations in CACNA1A and ATP1A2 in probands with common types of migraine","volume":"61","author":"Jen","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2005.01.027_bib14","unstructured":"Hille, B. Ionic channels of excitable membranes. 2nd ed. Sinauer; 1992"},{"key":"10.1016\/j.mehy.2005.01.027_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/pr.55.4.5","article-title":"International union of pharmacology: approaches to the nomenclature of voltage-gated ion channels","volume":"55","author":"Catterall","year":"2003","journal-title":"Pharm Rev"},{"key":"10.1016\/j.mehy.2005.01.027_bib16","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/ana.10364","article-title":"Changes of sodium channel expression in experimental painful diabetic neuropathy","volume":"52","author":"Craner","year":"2002","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1016\/j.mehy.2005.01.027_bib17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm1074","article-title":"The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions","volume":"10","author":"Rogawski","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.mehy.2005.01.027_bib18","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","article-title":"Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"55","author":"Silberstein","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2005.01.027_bib19","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1468-2982.2002.00386.x","article-title":"Migraine: preventive treatment","volume":"22","author":"Silberstein","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.mehy.2005.01.027_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1212\/WNL.26.2.121","article-title":"Amitriptyline in the prophylaxis of migraine","volume":"26","author":"Couch","year":"1976","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mehy.2005.01.027_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(02)02239-2","article-title":"Differential blockade of neuronal voltage-gated Na(+) and K(+) channels by antidepressant drugs","volume":"457","author":"Nicholson","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2005.01.027_bib22","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1097\/00000542-200306000-00028","article-title":"Assessment of differential blockade by amitriptyline and its N-methyl derivative in different species by different routes","volume":"98","author":"Gerner","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2005.01.027_bib23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00000542-200104000-00021","article-title":"Amitriptyline versus bupivacaine rat sciatic nerve blockade","volume":"94","author":"Gerner","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2005.01.027_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00000542-200101000-00024","article-title":"Effect of drugs used for neuropathic pain management on tetrodotoxin-resistant Na+ currents in rat sensory neurons","volume":"94","author":"Brau","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mehy.2005.01.027_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3959(02)00375-5","article-title":"Tricyclic antidepressants as long-acting local anesthetics","volume":"103","author":"Sudoh","year":"2003","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2005.01.027_bib26","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.pain.2004.04.027","article-title":"Site 1 sodium channel blockers prolong the duration of sciatic nerve blockade from tricyclic antidepressants","volume":"110","author":"Barnet","year":"2004","journal-title":"Pain"},{"issue":"Suppl 1","key":"10.1016\/j.mehy.2005.01.027_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199700321-00003","article-title":"Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphais on pharmacokinetics and effects on oxidative drug metabolism","volume":"32","author":"Presskorn","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.mehy.2005.01.027_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-2999(98)00955-8","article-title":"Inhibition by fluoxetine of voltage-gated ion channels in rat PC12 cells","volume":"367","author":"Hahn","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2005.01.027_bib29","first-page":"208","article-title":"Inhibition of neuronal Na+ channels by antidepressant drugs","volume":"284","author":"Pancrazio","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mehy.2005.01.027_bib30","series-title":"Headache","author":"Raskin","year":"1991"},{"key":"10.1016\/j.mehy.2005.01.027_bib31","unstructured":"Hardman JG, Limbird LL, editors in chief. Goodman and Gilman\u2019s. The pharmacological basis of therapeutics. 9th ed. McGraw-Hill; 1996. p. 852"},{"issue":"9","key":"10.1016\/j.mehy.2005.01.027_bib32","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/0006-2952(82)90668-2","article-title":"Effects of propanolol and a number of its analogues on sodium channels","volume":"31","author":"Matthews","year":"1982","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2005.01.027_bib33","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.bjp.0703369","article-title":"Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct action with Na(+) channels: comparison with other beta-adrenoceptor antagonists","volume":"130","author":"Chidlow","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2005.01.027_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(94)90257-7","article-title":"Effects of antiischemic drugs on ceratridine-induced hypercontracture in rat cardiac myocytes","volume":"271","author":"Hashizume","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2005.01.027_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1526-4610.1989.hed2907425.x","article-title":"Verapamil in migraine prophylaxis: a five year review","volume":"29","author":"Solomon","year":"1989","journal-title":"Headache"},{"key":"10.1016\/j.mehy.2005.01.027_bib36","series-title":"Basic and clinical pharmacology","year":"2001"},{"key":"10.1016\/j.mehy.2005.01.027_bib37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/00000542-200111000-00024","article-title":"Influence of voltage-sensitive Ca++ channel drugs on bupivacaine infiltration anesthesia in mice","volume":"95","author":"Smith","year":"2001","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.mehy.2005.01.027_bib38","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF03165424","article-title":"Effects of ion channel modulators in the influx and efflux of Tc-99m-MIDI","volume":"13","author":"Arbab","year":"1999","journal-title":"Ann Nucl Med Feb"},{"issue":"2","key":"10.1016\/j.mehy.2005.01.027_bib39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1742-7843.2004.pto940205.x","article-title":"Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects","volume":"94","author":"Fischer","year":"2004","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.mehy.2005.01.027_bib40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0306-4522(93)90229-9","article-title":"R56865 and flunarizine as Na(+)-channel blockers in isolated Purkinje neurons of rat cerebellum","volume":"54","author":"Kiskin","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.mehy.2005.01.027_bib41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1468-2982.1992.1202081.x","article-title":"Sodium valproate in the prophylactic treatment of migraine: a double blind study versus placebo","volume":"12","author":"Hering","year":"1992","journal-title":"Cephalalgia"},{"issue":"1-2","key":"10.1016\/j.mehy.2005.01.027_bib42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0006-8993(91)90907-D","article-title":"Phenytoin and retinal spreading depression","volume":"551","author":"Chebabo","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.mehy.2005.01.027_bib43","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/bmj.2.5207.1203","article-title":"Drug prophylaxis in migraine, a controlled clinical trial","volume":"5207","author":"Grahame","year":"1960","journal-title":"Brit Med J"},{"issue":"Suppl. 4","key":"10.1016\/j.mehy.2005.01.027_bib44","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1111\/j.1528-1157.1994.tb05955.x","article-title":"Mechanisms of action of currently prescribed and newly developed antiepileptic drugs","volume":"35","author":"Macdonald","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.mehy.2005.01.027_bib45","first-page":"627","article-title":"Inhibition of (3H)batrachotoxin A 20-a-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazapine","volume":"22","author":"Willow","year":"1982","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2005.01.027_bib46","first-page":"105","article-title":"Blockade of neuronal sodium channels by the antiepileptic drugs phenytoin, carbamazapine and sodium valproate","volume":"42","author":"Pugsley","year":"1999","journal-title":"Proc West Pharmacol Soc"},{"issue":"11","key":"10.1016\/j.mehy.2005.01.027_bib47","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/j.1528-1157.1999.tb02034.x","article-title":"Modulation of sodium currents in rat CA1 neurons by carbamazapine and valproate after kindling epileptogenesis","volume":"40","author":"Vreugdenhil","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.mehy.2005.01.027_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","article-title":"Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action","volume":"58","author":"Loscher","year":"1999","journal-title":"Prog Neurobiol"},{"issue":"11","key":"10.1016\/j.mehy.2005.01.027_bib49","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1528-1157.1999.tb02029.x","article-title":"The pharmacologic basis of antiepileptic drug action","volume":"40","author":"Rho","year":"1999","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.mehy.2005.01.027_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bjp.0704892","article-title":"T-channel-like pharmacological properties of high voltage-activated, nifedipine-insensitive Ca2+ currents in the rat terminal mesenteric artery","volume":"137","author":"Morita","year":"2002","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.mehy.2005.01.027_bib51","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4610.2001.111006119.x","article-title":"Efficacy of gabapentin in migraine prophylaxis","volume":"41","author":"Mathew","year":"2001","journal-title":"Headache"},{"key":"10.1016\/j.mehy.2005.01.027_bib52","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","article-title":"Gabapentin: pharmacology and its use in pain management","volume":"57","author":"Rose","year":"2002","journal-title":"Anaesthesia"},{"key":"10.1016\/j.mehy.2005.01.027_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(94)90074-4","article-title":"Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture","volume":"17","author":"Wamil","year":"1994","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.mehy.2005.01.027_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0920-1211(00)00201-1","article-title":"The effects of gabapentin on different ligand- and voltage-gated currents in isolated cortical neurons","volume":"43","author":"Stefani","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.mehy.2005.01.027_bib55","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha two-delta subunit of a calcium channel","volume":"27","author":"Gee","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2005.01.027_bib56","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bjp.0705246","article-title":"A comparison of Ca2+ channel blocking mode between gabapentin and verapamil: implication for protection against hypoxic injury in rat cerebrocortical slices","volume":"139","author":"Oka","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.mehy.2005.01.027_bib57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0028-3908(01)00181-2","article-title":"Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurons is dependent on culture conditions and channel subunit expression","volume":"42","author":"Martin","year":"2002","journal-title":"Neuropharmacol"},{"key":"10.1016\/j.mehy.2005.01.027_bib58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0028-3908(01)00172-1","article-title":"Inhibition of neuronal Ca2+ influx by gabapentin and pregabilin in the human neocortex","volume":"42","author":"Fink","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mehy.2005.01.027_bib59","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1001\/jama.291.8.965","article-title":"Topiramate for migraine prevention: a randomized controlled trial","volume":"291","author":"Brandes","year":"2004","journal-title":"J Am Med Assoc"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2005.01.027_bib60","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1528-1157.2000.tb02163.x","article-title":"An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action","volume":"41","author":"Shank","year":"2000","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2005.01.027_bib61","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1111\/j.1528-1157.2000.tb06048.x","article-title":"Effects of topiramate on sustained repetitive firing and spontaneous recurrent seizure discharges in cultured hippocampal neurons","volume":"41","author":"DeLorenzo","year":"2000","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2005.01.027_bib62","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/j.1528-1157.2000.tb02166.x","article-title":"Effects of topiramate on sodium-depent action potential firing by mouse spinal cord neurons in cell culture","volume":"41","author":"McLean","year":"2000","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2005.01.027_bib63","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/j.1528-1157.2000.tb02173.x","article-title":"Modulation of high-voltage-activated calcium channels in dentate gyrus cells by topiramate","volume":"41","author":"Zhang","year":"2000","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.mehy.2005.01.027_bib64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1468-2982.1999.1901064.x","article-title":"Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study","volume":"19","author":"D\u2019Andrea","year":"1999","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.mehy.2005.01.027_bib65","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1526-4610.2004.04198.x","article-title":"Preventing disturbing migraine aura with lamotrigine: an open study","volume":"44","author":"Pascual","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.mehy.2005.01.027_bib66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0028-3908(02)00400-8","article-title":"Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels","volume":"44","author":"Liu","year":"2003","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.mehy.2005.01.027_bib67","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S0028-3908(01)00004-1","article-title":"Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-regulated calcium channels in dissociated neurons of rat cortex","volume":"40","author":"Hainsworth","year":"2001","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.mehy.2005.01.027_bib68","first-page":"838","article-title":"Botulinum toxin A in the prophylactic treatment of migraine \u2013 a randomized, double-blind, placebo-controlled study","volume":"44","author":"Evers","year":"2004","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.mehy.2005.01.027_bib69","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1526-4610.1999.3908543.x","article-title":"Intranasal lidocaine for migraine: a randomized trial and open-label follow-up","volume":"39","author":"Maizels","year":"1999","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.mehy.2005.01.027_bib70","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1046\/j.1468-2982.2003.00623.x","article-title":"Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse","volume":"23","author":"Williams","year":"2003","journal-title":"Cephalalgia"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705000708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987705000708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T09:07:44Z","timestamp":1549184864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987705000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0306987705000708"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2005.01.027","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1040147.489067","asserted-by":"object"}]},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}